Klöckner Pentaplast to Add Lamination Line

Published: June 09, 2016

MONTABAUR, GERMANY | The Klöckner Pentaplast Group reports it will expand its high-barrier film lamination and coating capacities to reinforce the company’s commitment to the global pharmaceutical and medical industries. Beginning in early 2017, the company will use a state-of-the-art system to produce Aclar laminated pharmaceutical films from its site in Montabaur. The new line will be fully operational for the entire kp Pentapharm Aclar product range by the end of 2017.

As a result of this investment, the Klöckner Pentaplast facility in Bern, Switzerland, will also have added capacity available to produce PVdC-coated, high-barrier pharmaceutical films, while continuing to be a back-up site for Aclar lamination. Company says the plan strengthens its dedication to its global packaging customers by providing improved customer service and security of supply from multiple sites under a global DMF.

Markus Pischulti, business director, Pharmaceutical Films EMEA, says, “This capacity expansion is part of Klöckner Pentaplast’s long-term strategy to leverage our global footprint to maximize improvements across the value chain, with a focus on being even more responsive to our pharmaceutical customers’ needs now and in the future.”

This email address is being protected from spambots. You need JavaScript enabled to view it.